Search hospitals
>
Virginia
>
Charlottesville
University of Virginia
Claim this profile
Charlottesville, Virginia 22902
Global Leader in Type 1 Diabetes
Global Leader in Diabetes
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Heart Failure
917 reported clinical trials
137 medical researchers
Summary
University of Virginia is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Type 1 Diabetes, Diabetes, Cancer, Breast Cancer, Heart Failure and other specialties. University of Virginia is involved with conducting 917 clinical trials across 1,261 conditions. There are 137 research doctors associated with this hospital, such as Linda Duska, MD, Scott Lim, MD, Richard D. Hall, and Matthew J. Reilley.
Area of expertise
Type 1 Diabetes
University of Virginia has run 47 trials for Type 1 Diabetes. Some of their research focus areas include:
Diabetes
University of Virginia has run 41 trials for Diabetes. Some of their research focus areas include:
Top PIs
Linda Duska, MD
University of Virginia Cancer Center
6 years of reported clinical research
Scott Lim, MD
University of Virginia Health System
7 years of reported clinical research
Richard D. Hall
University of Virginia Cancer Center
2 years of reported clinical research
Matthew J. Reilley
University of Virginia Cancer Center
1 year of reported clinical research
Clinical Trials running at University of Virginia
Breast Cancer
Lung Cancer
Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Melanoma
Ovarian Cancer
Lymphoma
Multiple Myeloma
Chemoradiation
for High-risk Breast Cancer
The goal of this study is to evaluate the safety and effectiveness of adjuvant chemoradiation therapy in high-risk breast cancer patients who had received neoadjuvant chemotherapy before their lumpectomy and/or mastectomy and were found to have residual disease. As well as examine the effects of this treatment combination on the immune system.
Recruiting
3 awards
Phase 2 & 3
14 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting
2 awards
Phase 3
6 criteria
Tranexamic Acid
for Breast Reconstruction
Tranexamic acid (TXA) is a synthetic, competitive lysine receptor inhibitor on plasminogen. It ultimately stabilizes the fibrin matrix, therefore used as a hemostatic agent for various indications. While there has been indications for orthopedic and trauma surgery, there is no clear data for its role in patients who are undergoing free tissue transfer. Studies have shown that patients undergoing free tissue transfer can have transfusion rates ranging from 7.2% to 34.9%, which data also showing association between transfusion requirement and higher free flap failure rate. There has been a few retrospective studies that evaluated the effect of TXA in free tissue transfer and the results showed no increased risk of microanastomosis failure but some showing decreased blood loss. This study aims to further analyze the role of TXA in patients undergoing breast free flap reconstruction with randomized, prospective trial. Control group will not receive TXA while experimental group will receive TXA. Both groups will receive standard of care breast free flap surgery as well as post-op care, which is streamlined with Early Recovery After Surgery (ERAS) protocol. Their pre and post-op hemoglobin will be compared, as well as rates of transfusion, surgical outcome and surgical complications including hematoma, flap failure, and any other medical complications such as Deep Vein Thrombosis (DVT)/ Pulmonary Embolism (PE).
Recruiting
2 awards
Phase 4
1 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Virginia?
University of Virginia is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Type 1 Diabetes, Diabetes, Cancer, Breast Cancer, Heart Failure and other specialties. University of Virginia is involved with conducting 917 clinical trials across 1,261 conditions. There are 137 research doctors associated with this hospital, such as Linda Duska, MD, Scott Lim, MD, Richard D. Hall, and Matthew J. Reilley.
Where is University of Virginia located?
The University of Virginia Hospital is located at 1215 Lee Street, Charlottesville, VA 22903.
Who should I call to ask about financial aid or insurance network?
**University of Virginia (UVA) Hospital Financial Assistance:** - **Contact Information:** For financial assistance, reach out to UVA Patient Financial Services at 434.924.8718 or 866.320.9659 (toll-free), or via email at financialassistance@virginia.edu. - **Location:** 1215 Lee Street, Charlottesville, VA 22908. - **Services:** Assistance is available for uninsured and underinsured patients to obtain financial aid for necessary medical care. To request an application, contact them directly. **Insurance-Related Inquiries at UVA:** - **Contact Information:** For insurance inquiries, contact the Insurance & Billing department at 866.320.9659 or via email at askfinance@virginia.edu. - **Services:** Assistance with insurance issues and guidance on the financial aid process are provided. **UVA Health Outpatient Imaging Centreville Financial Assistance:** - **Contact Information:** For financial assistance, call 877-442-2989 (toll-free), email charitycare@patientfinancialsvcs.com, or download the application from their website. - **Eligibility:** Financial assistance is available for eligible patients receiving medically necessary services. The policy excludes services by independent physicians not employed by UVA Health Outpatient Imaging Centreville.
What insurance does University of Virginia accept?
The University of Virginia accepts multiple health insurance plans, including the UVA Health Plan/Pharmacy with Basic Health, Value Health, and Choice Health options, administered by Aetna. Coverage includes medical, dental, and vision benefits. Additionally, the University accepts Anthem HealthKeepers Plus (Medicaid), Anthem CCC Plus, and Blue Cross and Blue Shield Service Benefit Plan (Federal Employee Program or FEP).
What awards or recognition has University of Virginia received?
The University of Virginia (UVA) Hospital, located in Charlottesville, Virginia, is an NCI-designated comprehensive cancer center known for its scientific leadership, resources, and clinical expertise. It has been ranked among the nation's top hospitals by U.S. News & World Report, Newsweek, and the Leapfrog Group. UVA has received the highest possible rating for care in 5 specialties and 14 common conditions and procedures according to U.S. News & World Report.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.